News and Announcements
Proteomics Completes $1.44 million Placement and Offers SPP
- Published December 02, 2016 3:57PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
2nd December 2016, ASX Announcement
Medtech company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is pleased to announce it has completed the first phase of a targeted capital raising by placement of 6m shares at $0.24 to raise $1.44m (the “Placement”).
- Oversubscribed Placement raised $1.44 million with support from existing and new sophisticated investors
- Share Purchase Plan to raise a further $480,000
- Funds to be used to accelerate commercialisation of breakthrough test, PromarkerD, and the rollout of new analytical testing services for the fast-growing clinical trials market
- Directors to participate in the SPP
The Placement received strong support from existing and new sophisticated investors and was significantly over-subscribed. The Placement was priced at $0.24 per share, a discount of 12.7% to the last sale price and the 20 day VWAP, and includes one for four attaching options. PILL also announces a Share Purchase Plan (SPP) to existing shareholders to raise $480,000 at $0.24 per share. K S Capital Pty Ltd acted as Lead Manager to the Placement.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
